| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |